Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
epipens
gene therapy
generic drugs
life sciences
mylan
2
×
novartis
2
×
abbvie
adverum biotechnologies
albert bourla
alzheimer's disease
amgen
amicus therapeutics
arvinas
batten disease
bayer
biogen
bioinnovation capital
biolabs
boston
boston top stories
boulder/denver blog main
boulder/denver top stories
breast cancer
brian stuglik
cancer diagnostics
cancer immunotherapy
casimir trials
celenex
chemotherapy
christine mcsherry
chuck schumer
clinial trials
crispr therapeutics
cystic fibrosis
dan chevallard
daraprim
darolutamide
deals
What
drug
acquisitions
albert
biggest
bio
biotech
bourla
ceo
company
crispr
driving
future
good
healthcare
history
imports
improved
industry
innovation
innovations
investment
life
long
maker
maps
measured
medical
outcomes
patients
pfizer
pfizer’s
pricing
proud
public
revenue
roundup
sciences
today
wide
world’s
Language
unknown
unset
Current search:
mylan
×
novartis
×
@xconomy.com
4 years ago
Drug Pricing: Innovation, Investment, and the Public Good
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More